+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sodium Oxybate Oral Medications Market by Indication (Idiopathic Hypersomnia, Narcolepsy, Off-Label Use), Strength (Four Point Five Gram, Nine Gram, Seven Point Five Gram), Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast 2025-2030- Product Image
Sodium Oxybate Oral Medications Market by Indication (Idiopathic Hypersomnia, Narcolepsy, Off-Label Use), Strength (Four Point Five Gram, Nine Gram, Seven Point Five Gram), Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Sodium Oxybate Oral Medications Market by Indication (Idiopathic Hypersomnia, Narcolepsy, Off-Label Use), Strength (Four Point Five Gram, Nine Gram, Seven Point Five Gram), Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084840
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sodium oxybate is redefining therapeutic strategies for sleep disorders, with new innovations and evolving regulations shaping a dynamic global market. Senior decision-makers are pursuing actionable intelligence to navigate supply challenges, optimize patient outcomes, and deliver sustainable value in this complex landscape.

Market Snapshot: Sodium Oxybate Oral Medication Market

The sodium oxybate oral medication market is achieving notable expansion, propelled by its therapeutic prominence in managing idiopathic hypersomnia and narcolepsy. Recent years have seen consistent growth, driven by shifts in clinical protocols, regulatory adaptation, and heightened awareness of rare sleep conditions. 2025 projections highlight robust demand across hospital, specialty, and outpatient settings, reflecting both primary and off-label use. Strategic investments in digital health, packaging, and regional supply chains are accelerating accessibility and adherence, establishing new performance benchmarks for sodium oxybate therapy in the broader central nervous system depressant sector.

Sodium Oxybate Market Scope & Segmentation

This comprehensive assessment analyzes the sodium oxybate market across clinical, technological, and distributional dimensions:

  • Clinical Indications – Idiopathic hypersomnia, type one narcolepsy, type two narcolepsy, and off-label applications such as Kleine-Levin syndrome.
  • Strengths – 4.5 gram, 6 gram, 7.5 gram, and 9 gram dosages, supporting incremental titration and tailored regimens.
  • Distribution Channels – Hospital pharmacies, online pharmacies, retail pharmacies, and specialty pharmacies.
  • Dosage Forms – Liquid and powder formulations, enabling adaptability to patient and care setting preferences.
  • End Users – Home care providers, hospitals, and specialty clinics, addressing both adult and pediatric patient groups.
  • Packaging Types – Single dose and multi dose formats, optimized for various dosing and safety requirements.
  • Patient Age Groups – Segmentation by adults and pediatrics, supporting age-appropriate administration practices.
  • Regions – Coverage spanning Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with detailed country splits), and Asia-Pacific markets (China, India, Japan, Australia, and more).
  • Key Competitors – Jazz Pharmaceuticals plc, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals Inc, Breckenridge Pharmaceutical, Alvogen Pharma GmbH, Apotex Inc, Par Pharmaceutical Companies Inc, Lupin Limited, Sun Pharmaceutical Industries Ltd.

Key Takeaways for Decision-Makers

  • Therapeutic adoption is diversifying, with sodium oxybate applied in both core and rare sleep disorder segments, demanding ongoing innovation in clinical protocols and formulation science.
  • Integrated digital health technologies—remote titration, telemedicine, and mobile adherence apps—are enhancing patient engagement, improving monitoring, and enabling more precise titration with data-driven insights.
  • Regulatory and reimbursement landscapes remain variable across regions, requiring targeted go-to-market strategies and close engagement with payers, regulators, and advocacy groups to secure access and streamline product launches.
  • Distribution channel complexity is growing, with collaborative models among pharmacies, hospital networks, and digital providers increasingly critical in ensuring both access and cost efficiency.
  • Packaging and dosage customization are a key focus due to differentiated requirements across adult and pediatric populations, as well as between home care, clinics, and acute care settings.
  • Competitive activity is intensifying, with biosimilars, generics, and innovative delivery platform alliances challenging established leaders to differentiate via R&D, operational agility, and end-to-end patient support ecosystems.

Tariff Impact: United States 2025 Trade Policies

The implementation of 2025 U.S. tariffs is restructuring sodium oxybate supply chains, with import levies on gamma-hydroxybutyrate precursors increasing upstream costs. Pharmaceutical companies and compounding organizations are pivoting toward local and nearshore production to minimize supply risk, mitigate tariff exposure, and maintain continuity in patient access. Collaborative procurement alliances among hospital and pharmacy networks are also emerging, strengthening bargaining power and cost stability amid regulatory change.

Methodology & Data Sources

Analytical findings derive from expert interviews with sleep specialists, regulatory consultants, and supply chain practitioners, together with systematic reviews of clinical studies and policy documentation. Data triangulation validates patterns in dosing, adherence, and regional segmentation to ensure evidence-based reliability.

Why This Report Matters

  • Provides strategic clarity on evolving sodium oxybate market structure, competitive roles, and innovation pathways.
  • Equips decision-makers with tactical insights to proactively address supply, regulatory, and patient engagement challenges.
  • Delivers actionable guidance for optimizing commercialization and partnership models in changing global environments.

Conclusion

Sodium oxybate’s market trajectory is distinguished by expanding clinical use, technology-driven adherence gains, and regional diversification. Stakeholders equipped with thorough, validated analysis can drive sustainable value and adapt strategically as the market evolves.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of sodium oxybate labeling for pediatric narcolepsy and idiopathic hypersomnia use in underrepresented populations
5.2. Introduction of extended release oral film technologies to improve patient adherence and dosing convenience
5.3. Growing use of telemedicine platforms for remote monitoring and dose titration of sodium oxybate therapy
5.4. Increasing focus on real world evidence studies to demonstrate long term efficacy and safety outcomes
5.5. Emergence of generic and biosimilar sodium oxybate candidates reshaping competitive pricing and market access
5.6. Strategic partnerships between specialty pharmacies and manufacturers to optimize distribution and reimbursement
5.7. Health economic assessments highlighting cost effectiveness of sodium oxybate compared with alternative narcolepsy treatments
5.8. Patient centric digital health tools and mobile apps facilitating adherence tracking and adverse event reporting
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sodium Oxybate Oral Medications Market, by Indication
8.1. Introduction
8.2. Idiopathic Hypersomnia
8.3. Narcolepsy
8.3.1. Type One Narcolepsy
8.3.2. Type Two Narcolepsy
8.4. Off-Label Use
8.4.1. Kleine Levin Syndrome
9. Sodium Oxybate Oral Medications Market, by Strength
9.1. Introduction
9.2. Four Point Five Gram
9.3. Nine Gram
9.4. Seven Point Five Gram
9.5. Six Gram
10. Sodium Oxybate Oral Medications Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.5. Specialty Pharmacies
11. Sodium Oxybate Oral Medications Market, by Dosage Form
11.1. Introduction
11.2. Liquid
11.3. Powder
12. Sodium Oxybate Oral Medications Market, by End User
12.1. Introduction
12.2. Home Care
12.3. Hospitals
12.4. Specialty Clinics
13. Sodium Oxybate Oral Medications Market, by Packaging Type
13.1. Introduction
13.2. Multi Dose
13.3. Single Dose
14. Sodium Oxybate Oral Medications Market, by Patient Age Group
14.1. Introduction
14.2. Adults
14.3. Pediatrics
15. Americas Sodium Oxybate Oral Medications Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Sodium Oxybate Oral Medications Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Sodium Oxybate Oral Medications Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Jazz Pharmaceuticals plc
18.3.2. Hikma Pharmaceuticals PLC
18.3.3. Teva Pharmaceutical Industries Ltd
18.3.4. Amneal Pharmaceuticals Inc
18.3.5. Breckenridge Pharmaceutical, Inc
18.3.6. Alvogen Pharma GmbH
18.3.7. Apotex Inc
18.3.8. Par Pharmaceutical Companies, Inc
18.3.9. Lupin Limited
18.3.10. Sun Pharmaceutical Industries Ltd
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SODIUM OXYBATE ORAL MEDICATIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SODIUM OXYBATE ORAL MEDICATIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SODIUM OXYBATE ORAL MEDICATIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. SODIUM OXYBATE ORAL MEDICATIONS MARKET: RESEARCHAI
FIGURE 30. SODIUM OXYBATE ORAL MEDICATIONS MARKET: RESEARCHSTATISTICS
FIGURE 31. SODIUM OXYBATE ORAL MEDICATIONS MARKET: RESEARCHCONTACTS
FIGURE 32. SODIUM OXYBATE ORAL MEDICATIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SODIUM OXYBATE ORAL MEDICATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY IDIOPATHIC HYPERSOMNIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY IDIOPATHIC HYPERSOMNIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE ONE NARCOLEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE ONE NARCOLEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE TWO NARCOLEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE TWO NARCOLEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY KLEINE LEVIN SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY KLEINE LEVIN SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY FOUR POINT FIVE GRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY FOUR POINT FIVE GRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NINE GRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NINE GRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SEVEN POINT FIVE GRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SEVEN POINT FIVE GRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SIX GRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SIX GRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 116. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 117. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 118. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 119. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 120. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 121. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 124. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 125. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 134. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 138. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 139. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 226. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 234. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 235. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 240. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 241. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 244. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 245. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 280. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 281. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 282. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 283. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 284. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 285. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 288. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 289. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 292. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 293. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 294. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 295. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2024 (USD MILLION)
TABLE 298. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2025-2030 (USD MILLION)
TABLE 299. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2024 (USD MILLION)
TABLE 300. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2025-2030 (USD MILLION)
TABLE 301. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 302. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 303. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sodium Oxybate Oral Medications market report include:
  • Jazz Pharmaceuticals plc
  • Hikma Pharmaceuticals PLC
  • Teva Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals Inc
  • Breckenridge Pharmaceutical, Inc
  • Alvogen Pharma GmbH
  • Apotex Inc
  • Par Pharmaceutical Companies, Inc
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd

Related Topics

Related Reports

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report and Forecast 2024-2032 - Product Image

Narcolepsy Drugs Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Market Report 2025 - Product Image

Narcolepsy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Narcolepsy Drugs Market Report 2025 - Product Image

Narcolepsy Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.